18 FDG (Fludeoxyglucose 18F)

DRUG2 trials

Sponsors

National Cancer Institute (NCI), mahenoor alaa eldeen naem

Conditions

Hippel-Lindau DiseaseKidney CancerOncologic Diseases

Phase 2

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

CompletedNCT00088374

National Cancer Institute (NCI)Hippel-Lindau Disease, Kidney Cancer

Start: 2004-07-31End: 2009-01-31Updated: 2012-07-27

Unknown Phase

Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions

Not yet recruitingNCT06626932

mahenoor alaa eldeen naemOncologic Diseases

Start: 2024-10-31End: 2026-11-30Target: 259Updated: 2024-10-04

Related Papers

The Confluence of Nanotechnology and Heat Shock Protein 70 in Pioneering Glioblastoma Multiforme Therapy: Forging Pathways Towards Precision Targeting and Transformation.

2025-04-241 citations